Harrow (HROW) Non-Current Debt (2015 - 2026)
Harrow (HROW) recorded quarterly Non-Current Debt of $292.1 million in Q1 2026, up 20.11% quarter-over-quarter from $243.2 million in Q4 2025, and up 159.63% on a YoY basis from $112.5 million in Q1 2025.
Harrow (HROW) Non-Current Debt (2015 - 2026) Analysis & Trends
Harrow's Non-Current Debt history runs 12 years deep, the most recent figure standing at $292.1 million for Q1 2026.
- In Q1 2026, Non-Current Debt rose 159.63% year-over-year to $292.1 million; the TTM figure through Mar 2026 stood at $292.1 million (up 159.63% YoY), while the FY2025 annual figure was $243.2 million, up 10.77% from the prior year.
- Non-Current Debt was $292.1 million for Q1 2026 at Harrow, up from $243.2 million in the prior quarter.
- In the past five years, Non-Current Debt ranged from a high of $292.1 million in Q1 2026 to a low of $38.5 million in Q2 2025.
- Historically, Non-Current Debt has averaged $160.6 million across 5 years, with a median of $182.2 million in 2023.
- The sharpest annual moves came in 2022 and 2025: Non-Current Debt soared 553.39% in 2022, then slumped 79.2% in 2025.
- A 5-year view of Non-Current Debt shows it stood at $104.2 million in 2022, then jumped by 78.44% to $185.9 million in 2023, then increased by 18.1% to $219.5 million in 2024, then gained by 10.77% to $243.2 million in 2025, then rose by 20.11% to $292.1 million in 2026.
- The last three Non-Current Debt figures came in at $292.1 million (Q1 2026), $243.2 million (Q4 2025), and $242.9 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 14.02 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 9.05 Bn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | - |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | - |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 3.92 Bn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | 1.48 Bn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | - |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 569.60 Mn |
| 10 | Harrow | 1.25 Bn | 1.15 Bn | 27.05 Mn | 292.09 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 292.09 Mn |
| Mar 31, 2026 | 292.09 Mn |
| Dec 31, 2025 | 243.18 Mn |
| Dec 31, 2025 | 243.18 Mn |
| Sep 30, 2025 | 242.87 Mn |
| Sep 30, 2025 | 242.87 Mn |
| Jun 30, 2025 | 38.48 Mn |
| Jun 30, 2025 | 38.48 Mn |
| Mar 31, 2025 | 112.50 Mn |
| Mar 31, 2025 | 112.50 Mn |
| Dec 31, 2024 | 219.54 Mn |
| Dec 31, 2024 | 219.54 Mn |
| Sep 30, 2024 | 186.06 Mn |
| Sep 30, 2024 | 186.06 Mn |
| Jun 30, 2024 | 185.02 Mn |
| Jun 30, 2024 | 185.02 Mn |
| Mar 31, 2024 | 184.15 Mn |
| Mar 31, 2024 | 184.15 Mn |
| Dec 31, 2023 | 185.89 Mn |
| Dec 31, 2023 | 185.89 Mn |